133 related articles for article (PubMed ID: 22688763)
1. Screening for vaccinia virus egress inhibitors: separation of IMV, IEV, and EEV.
Byrd CM; Hruby DE
Methods Mol Biol; 2012; 890():113-21. PubMed ID: 22688763
[TBL] [Abstract][Full Text] [Related]
2. ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation.
Berhanu A; King DS; Mosier S; Jordan R; Jones KF; Hruby DE; Grosenbach DW
Antimicrob Agents Chemother; 2009 Dec; 53(12):4999-5009. PubMed ID: 19752270
[TBL] [Abstract][Full Text] [Related]
3. Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently.
Duraffour S; Vigne S; Vermeire K; Garcel A; Vanstreels E; Daelemans D; Yang G; Jordan R; Hruby DE; Crance JM; Garin D; Andrei G; Snoeck R
Antivir Ther; 2008; 13(8):977-90. PubMed ID: 19195323
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Poxvirus Gene Expression and Genome Replication by Bisbenzimide Derivatives.
Yakimovich A; Huttunen M; Zehnder B; Coulter LJ; Gould V; Schneider C; Kopf M; McInnes CJ; Greber UF; Mercer J
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659488
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility to ST-246 and Cidofovir corroborates the phylogenetic separation of Brazilian Vaccinia virus into two clades.
Pires MA; Rodrigues NFS; de Oliveira DB; de Assis FL; Costa GB; Kroon EG; Mota BEF
Antiviral Res; 2018 Apr; 152():36-44. PubMed ID: 29427676
[TBL] [Abstract][Full Text] [Related]
6. Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach.
Silverman JE; Ciustea M; Shudofsky AM; Bender F; Shoemaker RH; Ricciardi RP
Antiviral Res; 2008 Nov; 80(2):114-23. PubMed ID: 18621425
[TBL] [Abstract][Full Text] [Related]
7. An investigation of incorporation of cellular antigens into vaccinia virus particles.
Krauss O; Hollinshead R; Hollinshead M; Smith GL
J Gen Virol; 2002 Oct; 83(Pt 10):2347-2359. PubMed ID: 12237415
[TBL] [Abstract][Full Text] [Related]
8. The vaccinia virus 4c and A-type inclusion proteins are specific markers for the intracellular mature virus particle.
Ulaeto D; Grosenbach D; Hruby DE
J Virol; 1996 Jun; 70(6):3372-7. PubMed ID: 8648667
[TBL] [Abstract][Full Text] [Related]
9. Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures.
Duraffour S; Snoeck R; de Vos R; van Den Oord JJ; Crance JM; Garin D; Hruby DE; Jordan R; De Clercq E; Andrei G
Antivir Ther; 2007; 12(8):1205-16. PubMed ID: 18240860
[TBL] [Abstract][Full Text] [Related]
10. Rifampicin and poxvirus replication.
Ben-Ishai Z; Heller E; Goldblum N; Becker Y
Nature; 1969 Oct; 224(5214):29-32. PubMed ID: 5822902
[No Abstract] [Full Text] [Related]
11. Carbenoxolone-mediated cytotoxicity inhibits Vaccinia virus replication in a human keratinocyte cell line.
Haga IR; Simpson JL; Hawes PC; Beard PM
Sci Rep; 2018 Nov; 8(1):16956. PubMed ID: 30446704
[TBL] [Abstract][Full Text] [Related]
12. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface.
van Eijl H; Hollinshead M; Rodger G; Zhang WH; Smith GL
J Gen Virol; 2002 Jan; 83(Pt 1):195-207. PubMed ID: 11752717
[TBL] [Abstract][Full Text] [Related]
13. Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases.
Reeves PM; Smith SK; Olson VA; Thorne SH; Bornmann W; Damon IK; Kalman D
J Virol; 2011 Jan; 85(1):21-31. PubMed ID: 20962097
[TBL] [Abstract][Full Text] [Related]
14. Nigericin is a potent inhibitor of the early stage of vaccinia virus replication.
Myskiw C; Piper J; Huzarewich R; Booth TF; Cao J; He R
Antiviral Res; 2010 Dec; 88(3):304-10. PubMed ID: 20951746
[TBL] [Abstract][Full Text] [Related]
15. Fluorinated pyrimidines. 39. Effects of 5-trifluoromethyl-2'-deoxyuridine on the replication of vaccinia viral messenger ribonucleic acid and proteins.
Oki T; Heidelberger C
Mol Pharmacol; 1971 Nov; 7(6):653-62. PubMed ID: 5148900
[No Abstract] [Full Text] [Related]
16. Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion.
Sanderson CM; Frischknecht F; Way M; Hollinshead M; Smith GL
J Gen Virol; 1998 Jun; 79 ( Pt 6)():1415-25. PubMed ID: 9634084
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.
Deng L; Dai P; Ciro A; Smee DF; Djaballah H; Shuman S
J Virol; 2007 Dec; 81(24):13392-402. PubMed ID: 17928345
[TBL] [Abstract][Full Text] [Related]
18. Polycyclic N-benzamido imides with potent activity against vaccinia virus.
Torres E; Duque MD; Camps P; Naesens L; Calvet T; Font-Bardia M; Vázquez S
ChemMedChem; 2010 Dec; 5(12):2072-8. PubMed ID: 20967819
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus morphogenesis and dissemination.
Roberts KL; Smith GL
Trends Microbiol; 2008 Oct; 16(10):472-9. PubMed ID: 18789694
[TBL] [Abstract][Full Text] [Related]
20. ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.
Duraffour S; Lorenzo MM; Zöller G; Topalis D; Grosenbach D; Hruby DE; Andrei G; Blasco R; Meyer H; Snoeck R
J Antimicrob Chemother; 2015 May; 70(5):1367-80. PubMed ID: 25630650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
